| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |